1,250 g 미만 미숙아에서 예방적 Ibuprofen의 효과
Effect of Prophylactic Ibuprofen in Preterm Infants Less than 1,250 g in Birth Weight
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
목적: 최근 indomethacin의 대체약으로 ibuprofen이 미숙아동맥관 개존증의 예방과 치료에 사용되고 있다. 본 연구는 1,250g 미만의 미숙아를 대상으로 ibuprofen의 예방적 치료 효과 및임상 경과를 분석하고자 하였다. 방법: 2009년 11월부터 2010년 7월까지 본원 신생아 중환자실에 입원한 1,250 g 미만의 동맥관 개존증 환아 39명을 대상으로 후향적으로 의무기록을 조사하였다. Ibuprofen의 예방적 투여군(출생 후 24시간 이내에 ibuprofen 투여) 13명에 대해 재태연령과 출생체중을 과거 대응(historical match)하여 대조군 26명으로 분류하였고, 두 군의 동맥관 개존증 빈도, 임상 경과 및합병증을 분석하였다. 결과: Ibuprofen을 투여한 예방적 투여군과 대조군 간의 동맥관 폐쇄율(69.2% vs 77.7%, P=0.825)은 유의한 차이가 없었고,ibuprofen 치료에 실패하여 동맥관 결찰술을 시행 받은 경우도두 군간에 유의한 차이가 없었다(23.1% vs 30.8%, P=0.719). 약물과 관련된 부작용으로 위장관 천공이 발생한 경우는 예방적투여군에서 더 많은 경향을 보였으나 대상수의 부족 등으로 통계적 유의성은 없었다(30.8% vs 11.5%, P=0.194). 뇌실 내 출혈(grade≥3) 및 다른 미숙아 합병증의 발생률도 두 군간 차이는없었다. 결론: 미숙아에서 ibuprofen의 예방적인 투여가 동맥관 폐쇄율, 동맥관 결찰술 그리고 고도의 뇌실 내 출혈의 빈도를 감소시키지 못하였다. 향후 예방적 ibuprofen 사용과 관련하여 효과및 부작용에 대한 더 많은 연구가 되어야 할 것이다.
Abstract
Purpose: Ibuprofen is used for prevention and treatment of patent ductus arteriosus as an alternative drug of indomethacin in very premature infants. We aimed to determine the effect of prophylactic ibuprofen on patent ductus arteriosus and clinical outcomes in preterm infants less than 1,250 g. Methods: A retrospective review of 39 preterm infants who were admitted to our neonatal intensive care unit from November 2009to July 2010 was performed. Patients were divided into a prophylactic group (n=13) and a matched historical control group (n=26),where prophylactic ibuprofen were administrated within 24 hours after birth. The rate of ductal closure, side-effects of drug treatment and clinical outcomes were compared between two groups. Results: Comparison of the prophylactic and control groups revealed no significant differences in the rate of ductal closure (69.2%vs 77.7%, P=0.825) and surgical ligation (23.1% vs 30.8%, P=0.719). Occurrence of bowel perforation was more frequent in the prophylactic group than the control group, but was not significant (30.8% vs 11.5%, P=0.194). The frequency of intraventricular hemorrhage (grade≥3) and other outcomes did not differ between the groups. Conclusion: Ibuprofen prophylaxis in preterm infants did not decrease the rate of ductal closure, the need for surgical ligation and the incidence of intraventricular hemorrhage. Further studies are needed to investigate the beneficial effect and associated adverse events attributed to ibuprofen prophylaxis.
참고문헌 (29)
- Ohlsson A, "Ibuprofen for the treatment of patent ductus arteriosus in preterm and", or low birth weight infants, 2010, pp.(4), CD003481~
- Patel J, "Randomized double-blind controlled trial comparing the effects of ibuprofen with indomethacin on cerebral hemodynamics in preterm infants with patent ductus arteriosus", Pediatr Res, 48, pp.36~42 (2000)
- Pezzati M, "Effects of indomethacin and ibuprofen on mesenteric and renal blood flow in preterm infants with patent ductus arteriosus", J Pediatr, 135, pp.733~738 (1999)
- Romagnoli C, "Effects of prophylactic ibuprofen on cerebral and renal hemodynamics in very preterm neonates", Clin Pharmacol Ther, 67, pp.676~683 (2000)
- Van Overmeire B, "A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus", N Engl J Med, 343, pp.674~681 (2000)
- Ohlsson A, "Ibuprofen for the prevention of patent ductus arteriosus in preterm and", or low birth weight infants, 2011, pp.(7), CD004213~
- Van Overmeire B, "Prophylactic ibuprofen in premature infants: A multicentre, randomised, double-blind, placebo-controlled trial", Lancet, 364, pp.1945~1949 (2004)
- Richards J, "A second course of ibuprofen is effective in the closure of a clinically significant PDA in ELBW infants", Pediatrics, 124, pp.e287~e293 (2009)
- Papile LA, "Incidence and evolution of subependymal and intraventricular hemorrhage : a study of infants with birth weights less than 1,500 gm", J Pediatri, 92, pp.529~534 (1978)
- Jobe AH, "Bronchopulmonary dysplasia", Am J Respir Crit Care Med, 163, pp.1723~1729 (2011)
- Walsh MC, "Necrotizing enterocolitis: treatment based on staging criteria", Pediatr Clin North Am, 33, pp.179~201 (1986)
- "An international classification of retinopathy of prematurity", Pediatrics, 74, pp.127~133 (1984)
- Fujii AM, "Neonatal necrotizing enterocolitis with intestinal perforation in extremely premature infants receiving early indomethacin treatment for patent ductus arteriosus", J Perinatol, 22, pp.535~540 (2002)
- Knight DB, "The treatment of patent ductus arteriosus in preterm infants. A review and overview of randomized trials", Semin Neonatol, 6, pp.63~73 (2001)
- Ment LR, "Low-dose indomethacin therapy and extension of intraventricular hemorrhage: a multicenter randomized trial", J Pediatr, 124, pp.951~955 (1994)
- Clyman RI, "Patent ductus arteriosus: evidence for and against treatment", J Pediatr, 150, pp.216~219 (2007)
- Bancalari E, "Patent ductus arteriosus and respiratory outcome in premature infants", Biol Neonate, 88, pp.192~201 (2005)
- Clyman RI, "Effect of gestational age on ductus arteriosus response to circulating prostaglandin E2", J Pediatr, 102, pp.907~911 (1983)
- Schmidt B, "Long-term effects of indomethacin prophylaxis in extremelylow- birth-weight infants", N Engl J Med, 344, pp.1966~1972 (2001)
- Narayanan M, "Prophylactic indomethacin: factors determining permanent ductus arteriosus closure", J Pediatr, 136, pp.330~337 (2000)
- Lee HS, "Usefulness of B-type natriuretic peptide assay in predicting symptomatic patent ductus arteriosus in preterm infants", J Korean Soc Neonatol, 11, pp.44~53 (2004)
- Kim SM, "Therapeutic strategics for PDA in prematurity (How to treat PDA? When to treat PDA?)", J Korean Soc Neonatol, 14, pp.142~152 (2007)
- Dani C, "Prophylaxis of patent ductus arteriosus with ibuprofen in preterm infants", Acta Paediatr, 89, pp.1369~1374 (2000)
- Gournay V, "Prophylactic ibuprofen versus placebo in very premature infants: a randomised, double-blind, placebo-controlled trial", Lancet, 364, pp.1939~1944 (2004)
- Koch J, "Prevalence of spontaneous closure of the ductus arteriosus in neonates at a birth weight of 1000 grams or less", Pediatrics, 117, pp.1113~1121 (2006)
- Sangtawesin V, "Oral ibuprofen prophylaxis for symptomatic patent ductus arteriosus of prematurity", J Med Assoc Thai, 89, pp.314~321 (2006)
- Waleh N, "Patent ductus arteriosus ligation alters pulmonary gene expression in preterm baboons", Pediatr Res, 69, pp.212~216 (2011)
- 최욱선, "미숙아 동맥관 개존 치료에서 indomethacin과 ibuprofen의 효과", Korean Journal of Pediatrics, 49(12), pp.1315~1323 (2006), 대한소아과학회
- 이수진, "호흡곤란 증후군 미숙아에서 동맥관 개존증의 약물 치료 : 경구용 ibuprofen과 indomethacin의 비교", Korean Journal of Pediatrics, 51(9), pp.956~963 (2008), 대한소아과학회